statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The law firm of Robbins Geller Rudman & Dowd LLP announces that the GoodRx class action lawsuit seeks to represent purchasers or acquirers of GoodRx Holdings, Inc. (NASDAQ: GDRX) common stock between...

GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! GDRX INVESTOR ALERT...

GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) (GoodRx or the...

GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm

GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results...

GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call

GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.

 Latest Ratings for GDRX
 DateFirmActionFromTo Mar 2022BarclaysMaintainsOverweight Mar 2022Morgan...

GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings

GoodRx Holdings files to sell 99.98M shares for holders...

GoodRx Holdings files to sell 99.98M shares for holders

GoodRx Holdings, Inc. (NASDAQ:GDRX  Get Free Report) has received a consensus rating of Hold from the eighteen analysts that are covering the company, MarketBeat Ratings reports...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.62 Consensus Target Price from Analysts

Shares of GoodRX (NASDAQ: GDRX) rallied 7.5% today, as the prescription drug price-comparison site and telehealth platform garnered a positive upgrade from analysts at Wells Fargo. Monday's...

Why GoodRx Surged Today

GoodRx Holdings, Inc. (NASDAQ:GDRX  Get Free Report) has received an average rating of Hold from the eighteen brokerages that are presently covering the company, Marketbeat...

Brokerages Set GoodRx Holdings, Inc. (NASDAQ:GDRX) PT at $8.62

Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.

 Latest Ratings for...

Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.

Volume	558,378.00
52-Wk High	$9.37
52-Wk Low	$4.14

GDRX GoodRx Holdings Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals